2014
DOI: 10.1097/hp.0000000000000035
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of Prussian Blue on 137Cs Decorporation Therapy

Abstract: Prussian blue (PB) is an efficient drug for enhancing cesium elimination from the body. Literature data on the efficacy of PB treatment in dosages that vary from 1-10 g d was reviewed. Cesium biokinetics was simulated using a detailed systemic biokinetic model. The same model was used to simulate the maximum action of PB by interrupting the enterohepatic circulation. Model results reproduced reasonably well the literature data on the efficacy of PB administered to humans after incidental cesium intakes, as wel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
24
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(24 citation statements)
references
References 16 publications
0
24
0
Order By: Relevance
“…These procedures are time consuming and may take days or even weeks before results are available. As the efficacy of decorporation treatment depends on the time the treatment is started [7,8], it has been advocated to begin therapy as soon as possible, even if the committed effective dose is still unknown, also in consideration of the mild side-effects of therapy in the short run [9]. According to the guidelines of the French authority for nuclear safety [10] decorporation treatment should even be started on suspicion "à priori" within 2 h after incorporation ("urgent approach").…”
Section: Discussionmentioning
confidence: 99%
“…These procedures are time consuming and may take days or even weeks before results are available. As the efficacy of decorporation treatment depends on the time the treatment is started [7,8], it has been advocated to begin therapy as soon as possible, even if the committed effective dose is still unknown, also in consideration of the mild side-effects of therapy in the short run [9]. According to the guidelines of the French authority for nuclear safety [10] decorporation treatment should even be started on suspicion "à priori" within 2 h after incorporation ("urgent approach").…”
Section: Discussionmentioning
confidence: 99%
“…Prussian Blue (PB) is a blue pigment that is not absorbed out of the gut, and given orally it can bind cesium-137 in the lumen of the intestine, preventing its reabsorption and thus enhancing its elimination through the feces [7]. Pharmacokinetic considerations indicate that a PB therapy is particularly effective if initiated early after the incorporation [8,9]. Thus, the initiation of a treatment as soon as possible seems prudent, particularly as the adverse effects of the treatment are reported as only slight [10].…”
Section: The Controversy On Cesium-137 Decorporation Strategiesmentioning
confidence: 99%
“…Possible discounts or rebates granted by the manufacturer in a procurement process were not considered. Assuming a usual therapeutic dosage of 3 × 1 g PB per day [9], the purchase costs of treatment amount to 15.53 €/day. The daily costs were used to establish a linear cost function with an intercept value of 0.…”
Section: Evaluation Of Costsmentioning
confidence: 99%
“…A well-known MOF is Prussian blue, which contains Fe(II), Fe(III), and CN -and has a porous three-dimensional structure which is effective to adsorption of gas molecules or ions. Recently, Prussian blue has been studied for the selective adsorption of radioactive Cs + from contaminated water [2] and the human body [3]. MOFs typically have high gas adsorption efficiencies because of their varied pore sizes [4].…”
Section: Introductionmentioning
confidence: 99%